{"name":"Abide Therapeutics","slug":"abide-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNaFYyRUpoRFhCTVRaaWN4OVN3clJkekZtQ2dXQ0hSZW50bkVnaU83YXUxc3FoM0tMVm9jMlRnV3J1YVRVc3BhOWp5WmRRSUJIdFZDdDNxelRwYTdqbjdObFBES0hXLUJlNW5MekZ0N0U0NHl4dmJUMnV6V1E5OTVtSzBITk9aTFkxVXdJLVVGYnBMazYyc3QyWHJTbTdiRzA3U1ZuU3RXdWZCVjNMazJZWWFnZXFPWkZWYWNOdllTWQ?oc=5","date":"2026-03-10","type":"pipeline","source":"Nasdaq","summary":"CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight - Nasdaq","headline":"CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncolog","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE9UVUFlQXUtdXJYaHdaVGJkOVB0RXlCWmlySzBnak5FUjVpQ05JMXJzdTd5VHRlMDA3SWhXSEZ4Tm5TVFpKVU9qUEIzZE5nZFAyTHNCWE82RThaQQ?oc=5","date":"2025-05-12","type":"pipeline","source":"BBC","summary":"Trump's order on US drug prices: What's in it, and will it work? - BBC","headline":"Trump's order on US drug prices: What's in it, and will it work?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNak1hLTVRYXJCTkMtTDZmYmp5bDN6V2lnVUNpSGhBQVcxUS0xajhpN0dfQmV1V3lkcmdFLVBKVlZjeGMyUjRESDJqTzZFc0FpUjEySzdZclkxd2xvSU5Ub0FPd2RqVFoxWHhySWRrZThSekFqZmZJNFhDM3FSYTVlc2tyNWgyWXF0X19PeVkwc29jLTRaTUZiOXJsWVV3ZVo4WlBEc0poX29EdUI5QW5majdR?oc=5","date":"2025-04-11","type":"regulatory","source":"Fierce Pharma","summary":"After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use - Fierce Pharma","headline":"After Hetlioz's rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOTnN0NFpDV1dxVjJzbmttSFFkNGlrZ2NyUHJ0cEZxaHJ0eURiUjFmSEZqNF9WVkZuaUtzMUotbHpTZnMwbTBqMmFiMHgyNWtTS1dqVGNJNDg2WG1zU2x3Nm5aVXJXd044djk5clB6ODA2MVVsUTJmVmtvdEYzN2Vtc3ZMa2VBQmZUR1pIWG9uRmozaTB5aVBGaWxvUUxiUQ?oc=5","date":"2024-10-24","type":"deal","source":"Fierce Biotech","summary":"Lundbeck slashes value of $250M Abide buyout after pain setback - Fierce Biotech","headline":"Lundbeck slashes value of $250M Abide buyout after pain setback","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQS2VHSU42M3B1RXQ4bUJnT2xfRFdxcTFULTJYZndGMTlQT2dBaUp2R0daMzZXMHFPZU9vWDQ0a0dTME9OVmlQVkp2bTFKZ04xVng1TUNVbGY4MllHbURIcTNiV3hNZlpkR0E1U2FEZVZOaXFqbGYxN2h5RUpaOWp1MmszTFk3bW1tTXlCNnB1RVgyNncwY1Npend1ZlNrSS00QmhWcWFUZ1ppd1gzUk4tRW9LQzNpVzRxVmdpNzdObWhobnB5WE1KNmhiNGlRVkFCSEl2VHREVFd4SDBqQnBKSU5oMUVZTUZHQjNseVNmTndfUndUZUw4?oc=5","date":"2023-04-11","type":"pipeline","source":"PR Newswire","summary":"DelveInsight Evaluates a Robust Epilepsy Pipeline as 70+ Influential Pharma Players to Set Foot in the Domain - PR Newswire","headline":"DelveInsight Evaluates a Robust Epilepsy Pipeline as 70+ Influential Pharma Players to Set Foot in the Domain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE54WjVnSmk0Tm5rVnZpUk5HSDdUdDNqcWQ0UElRaENMS0I1bVBxOHVvc0dLNXFPZGZSSTJWUUhZQkc3SEwzb0p0QUZhVUxRU0syQ2JSS1JaMVZ3NEctSTZv?oc=5","date":"2021-04-12","type":"pipeline","source":"nature.com","summary":"People - nature.com","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQTThQdzJrejlqTlVUTDhUMWNpSzdNV3F1Q2dhZzlZYjJpTEU3YkdfNnpsMlFtQ3daYnRPVjJYU1kzTEJtV0hHbmlHOERMV3lOT1lMcVh2YTMyT3pfTjRxcE5VWVM5Q0x0bXlhOEQxSHJoMTVwM0c0c1RNd281UnFXZEt4d1UtdElVY0gxaw?oc=5","date":"2019-05-07","type":"deal","source":"Pharmaceutical Technology","summary":"Lundbeck to takeover Abide Therapeutics in $400m deal - Pharmaceutical Technology","headline":"Lundbeck to takeover Abide Therapeutics in $400m deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPdnRIUUJKRjdCX214MENhTlNCQWVVTEJCYmVaN1BJdW10ZXpvUHZ3WGtJMzdCSGhvemtMajZxYk0wOGd2ajMzUEp0Y0JxMXU3enJXU2tPTzZDQkdOZGZudUVQRjl2Z1JqRHlzRGlQSTZqN0lfSVlZNHgtZml3dWFtck5zNXdVNy0tQVVSaks0QXJzWFhnSWwzZGlscmg2cmc?oc=5","date":"2019-05-06","type":"deal","source":"BioSpace","summary":"Lundbeck Acquires Abide Therapeutics for $250M, Gains San Diego Discovery Site - BioSpace","headline":"Lundbeck Acquires Abide Therapeutics for $250M, Gains San Diego Discovery Site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxNVW1HNEhzUW0xaGxxaTg4NGpobDl4RFpzZVB0eW05WUdUZHcwNzFFalBQRndkcG4yVERkOWZ3U3QwaHZ0VDNfa3hVeVhEV2lUOFJSRXRpWEd3QXExVDc1cURqbFNqWkhsX0ZvbXItRGpLTXFUN3d4dVQxNk1IbDNGLU9QM3NMNDkwQVBPeHZmQlVJYmlQbDF6RVcwb2F5M280YTY3Nl94a2kyLUlnVUE0RjFzNnEtSDNGczc2X2Exb25ZU0VJc3hENFBwNG9wS1l0dU5yMDZkT2dKLUNEM0FJUVlLRy1CWkZ1YWVEd3hobWloTVJqRlJqTU52enRuTGk1eV81a1lKeTVZQThYdUFCOS1XMnlrUndxc1F1eXlTRF9QUGFUMElFaGwyb0xaRTlxdXk4MXdEWkpuTXp5?oc=5","date":"2019-05-06","type":"deal","source":"globenewswire.com","summary":"Lundbeck to acquire Abide Therapeutics, adding a unique - globenewswire.com","headline":"Lundbeck to acquire Abide Therapeutics, adding a unique","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOQkJVbjJlRUc2WC1tV1RWd0gwRERnNERLWDJhT2JzRkpYMTVabzVZYXlvMmtNMVZ4OXBpQjdaaFpRTnlOSkg4UkZDVVhuTTVySzlHeGM2VzVwVkN4SjZoVWNWS1lVcjZKbjdQaU5BUUVtOVZkQURya2hLaXE3akJqSUlPVXpsdlkyQUhMSmYxSkpoNm0wS2hzWFlONUMtUEFFZzl5QnVFUQ?oc=5","date":"2019-05-06","type":"pipeline","source":"BioPharma Dive","summary":"Lundbeck builds out brain drug pipeline with $250M acquisition - BioPharma Dive","headline":"Lundbeck builds out brain drug pipeline with $250M acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPdzFXSnBKMVVYaHRpbnlwWHp1ZnUwNHVzX2VicEJicHEzRXgtamptX0NHTVh0cHQzcmhZMnJPdXdIbEsyMlFEYUdVSWhnVDk1dDdMNXp3bkJCRjFqLXFrcVp0SDRpbl9FX3p6R2Z3UWlTWktxbEFiZVotZlc2WGN2blQwdlc5VnJidExmNjI4a1B5TGtTajlOQUQwdzJlWVdfTVRhaXpleElSMl8yMDFkUTNRN1I2cl96REU2cWRxTkxiWE12UEhxQzgtM1VQZw?oc=5","date":"2019-05-06","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Lundbeck to Acquire Abide for Up to $400M, Bolstering Neurology Pipeline - Genetic Engineering and Biotechnology News","headline":"Lundbeck to Acquire Abide for Up to $400M, Bolstering Neurology Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNOGdUbkVWNWRSOEtJWlVoX1VzaHY4U3k1eGwyTFhKcWM1ZjhrM2ZoQWdORVV5Yk9VeXFncWV5d0FVemx1aHBxTEkyVHEzaU5ROFNFS3hWQ3pOLUdGV1oxSk9BdXlpWEdHSGFrdVllck1Oa3E1aVZ4d19YSGxhcmdzd3pLX3huaEJxUGxiQU9JXy1SUm83aEtyZ0R5dHE?oc=5","date":"2019-05-06","type":"deal","source":"Fierce Biotech","summary":"Lundbeck strikes $250M Abide buyout, bagging Tourette's drug - Fierce Biotech","headline":"Lundbeck strikes $250M Abide buyout, bagging Tourette's drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}